Argent Biopharma Limited has released a press release.
ArtemiC Long COVID Syndrome Clinical Study Commenced
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- UK Capital Raising Completed
- Production Completed of A$1M ArtemiC Order from SPC
- US Supply and Distribution Agreement Update
- Malta cimetra production facility update
- Cimetra dose finding study approval
Later from Argent Biopharma
- ArtemiC receives Indian importation and sales approval
- Response to ASX Query
- Sciensus Rare EU & UK Sales and Distribution Agreement
- Patent Granted for CimetrA
- March 2022 Quarterly Activity and Cash Flow Reports
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma